MIAMI & BARRANQUILLA, Colombia --(BUSINESS WIRE)--May 20, 2024-- Procaps Group (Nasdaq: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has received a letter from the Nasdaq Stock Market , dated May 16, 2024 (the
MIAMI & BARRANQUILLA, Colombia --(BUSINESS WIRE)--May 14, 2024-- Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file its Annual Report on Form 20-F for the
MIAMI & BARRANQUILLA, Colombia --(BUSINESS WIRE)--May 1, 2024-- Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file its Annual Report on Form 20-F for the
MIAMI & BARRANQUILLA, Colombia --(BUSINESS WIRE)--Mar. 4, 2024-- Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it is conducting a process to explore strategic alternatives to maximize
MIAMI & BARRANQUILLA, Colombia --(BUSINESS WIRE)--Feb. 5, 2024-- Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today issued a letter to shareholders from Jose Vieira , CEO of Procaps .
MIAMI & BARRANQUILLA, Colombia .--(BUSINESS WIRE)--Jan. 16, 2024-- Dear Shareholders, We became aware on Saturday, January 13, 2024 , that the online voting instructions related to the upcoming General Meeting of Shareholders of the Company scheduled for January 22, 2024 , were incorrect.
